Abstract
Adjuvant diagnostic and therapeutic procedures reduce the risk of recurrence and progression in high-risk non-muscle-invasive bladder cancer (NMIBC) (Poletajew et al. in Neoplasma 65(1):147–152, 2018). However indications and oncological outcomes are varied. Poletajew et al. (Neoplasma 65(1):147–152, 2018), reviewed therapeutic decisions in primary high-risk NMIBC and adherence to clinical guidelines in this field. This chapter deals with prognostic factors in endoscopic resection in NMIBC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have